Commentary on "possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"

Research output: Contribution to journalComment / DebateOtherpeer-review

2 Citations (Scopus)

Abstract

The case report that is the subject of this Commentary describes a 27-year-old woman, who, 3 months after a devastating low cervical myelitis, underwent intrathecal mesenchymal stem cell (MSC) infusions. Six hours after the third infusion, she became unconscious, febrile and cerebral MRI showed acute bitemporal and left cerebellar lesions, consistent with an acute disseminated encephalomyelitis. It is likely that this is the first reported patient with neuroinflammatory exacerbation after MSC therapy. This case suggests that, in addition to their malignant potential, autologous MSC expanded in vitro can exhibit immune-activating properties leading to autoimmune exacerbation.

Original languageEnglish
Pages (from-to)312-313
Number of pages2
JournalJournal of Clinical Neuroscience
Volume20
Issue number2
DOIs
Publication statusPublished - 1 Jan 2013
Externally publishedYes

Keywords

  • Mesenchymal stem cell therapy
  • Multiple sclerosis
  • Serious adverse event

Cite this